Hepatobiliary manifestations in children with inflammatory bowel disease: A single-center experience in a low/middle income country

doi:10.4292/wjgpt.v11.i3.48

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7954)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

368

WORD

142

HTML

3040

Figures (1-3)

351

Tables (1-2)

293

Sum=4194

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

384

Download

995

Sum=1379

Publishing Process of This Article

Item

Count

Browse

744

Download

1637

Sum=2381

Aug 8, 2020 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastrointest Pharmacol Ther. Aug 8, 2020; 11(3): 48-58
Published online Aug 8, 2020. doi: 10.4292/wjgpt.v11.i3.48

Full Size Figure Download Figure

Figure 2 Magnetic resonance cholangiopancreatography of a patient with inflammatory bowel disease and primary sclerosing cholangitis showing dilatation of the intra- and extra-hepatic biliary tree with multiple strictures (arrows).

Citation: El-Shabrawi MH, Tarek S, Abou-Zekri M, Meshaal S, Enayet A, Mogahed EA. Hepatobiliary manifestations in children with inflammatory bowel disease: A single-center experience in a low/middle income country. World J Gastrointest Pharmacol Ther 2020; 11(3): 48-58
URL: https://www.wjgnet.com/2150-5349/full/v11/i3/48.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v11.i3.48